Status:
UNKNOWN
Effect of L-Citrulline Supplementation on Arginase Activity and Vascular Function in Diabetes
Lead Sponsor:
University of Jordan
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
45-70 years
Phase:
NA
Brief Summary
Arginase has recently been implicated in an array of vascular conditions including atherosclerosis , hypertension and vascular complication of diabetes. In this study we will determine of L-citrulline...
Detailed Description
Vascular dysfunction is a major cause of morbidity and mortality in diabetic patients. The pathological process is characterized by impaired endothelial cell production of the vasodilator and antiplat...
Eligibility Criteria
Inclusion
- Type 2 diabetes Diabetic state: HbA1c\>6
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03358264
Start Date
January 1 2017
End Date
December 31 2018
Last Update
November 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Jordan
Amman, Jordan, 11942